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A 50-year-old man presented with a brief history of slurred speech, unsteadiness, double vision and paraesthesia.
He had been unwell for 12 days with campylobacter gastroenteritis. On examination, there was ophthalmoplegia,
nystagmus, areflexia and lower limb and gait ataxia. Serological testing was positive for GQ1b antibody in keeping
with the diagnosis of Miller Fisher Syndrome (MFS). He was treated with two courses of intravenous immunoglobulins
and made a good recovery, only displaying mild gait ataxia when reviewed in clinic 2.5 months later.
There has long been a debate as to whether the ataxia in MFS originates in the cerebellum or it is more peripheral. In
this case, magnetic resonance spectroscopy (MRS) revealed a reduced NAA/Cr ratio in the cerebellar vermis and right
cerebral hemisphere, suggestive of cerebellar dysfunction. The NAA/Cr normalised 2.5 months later reflecting the
clinical recovery. The findings on MRS suggest that the cerebellum is involved in MFS.
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Miller Fisher syndrome (MFS) is a variant of Guillain-
Barre Syndrome (GBS), accounting for approximately
5% of acute inflammatory polyneuropathies. The pre-
dominant features of MFS are ophthalmoplegia and
ataxia, with a peripheral neuropathy being only a very
mild clinical feature. This is in contrast to GBS, where
weakness and sensory disturbance are usually the pre-
senting features [1,2]. Ever since the first publications of
cases of MFS there has been a debate as to whether the
ataxia is central or peripheral in origin. We report a pa-
tient with some evidence in support of cerebellar
involvement.Case report
Clinical case
A 50-year-old manual laborer presented to the Emer-
gency Department with a 24-hour history of slurred
speech, unsteadiness, double vision and pin & needles
affecting both hands. He was also complaining of nasal
regurgitation of fluids. The only past medical history
was of stage 1 hypertension, for which he was on no
medication. He had been feeling generally unwell for the* Correspondence: m.hadjivassiliou@sheffield.ac.uk
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unless otherwise stated.past 12 days and had non-bloody diarrhea. Stool culture
performed by his General Practitioner grew Campylo-
bacter jejuni. He was not treated with antibiotics.
On admission, he was noted to have a nasal speech.
There was poor palatal elevation. He had limitation of
eye movement and nystagmus on left lateral gaze. The
patient reported no diplopia during the examination.
There was no peripheral motor deficit. Knee and triceps
reflexes were absent bilaterally with wrist, bicep and
ankle reflexes being present. Plantars were down going.
There was some patchy sensory loss. He had dysdiado-
chokinesia, lower limb and gait ataxia.
Cerebrospinal fluid (CSF) analysis showed mildly ele-
vated protein (0.5 mg/L, upper limit of normal 0.45 mg/L).
Serological testing showed positive GQ1B antibodies in
support of the diagnosis of MFS. Results of nerve conduc-
tion studies were consistent with a diagnosis of MFS show-
ing mild disturbance in sensory conduction parameters
with normal motor responses. There was no evidence of
demyelination. Speech and Language Therapy assessment
recommended nasogastric feeding due to the unsafe swal-
low and eventually the patient required a percutaneous
endogastric tube for feeding.
Magnetic resonance spectroscopy (MRS) of the brain was
performed, which identified reduced N-acetylaspartate/cre-
atine (NAA/Cr) ratio of 0.9 at the superior cerebellar vermis,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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viduals both values should be above 1).
He was treated with a 5-day course of Intravenous Im-
munoglobulins (IVIg). His FVC was 3.13 L during treat-
ment and he did not report any respiratory problems.
Due to slow recovery and feeding difficulties he had a
further 5-day course of IVIg 2 weeks later. His FVC and
mobility improved. His speech returned to normal and
he was transferred to a local rehabilitation unit. On dis-
charge, he still complained of blurred vision, which was
attributed to incompletely resolved ophthalmoplegia.
He was reviewed in clinic after discharge from the re-
habilitation centre 2.5 months after the acute admission.
Clinical examination showed normal eye movements
with no residual limb ataxia. He still had some problems
with mild gait ataxia as evident by mild difficulty in
tandem walking. Repeat MRS at that stage showed
normalization of NAA/Cr from the hemisphere at 1.01
and a similar value from the vermis perhaps reflecting
the residual gait ataxia. A further review of the patient
3 months later showed complete resolution of the gait
ataxia.
Discussion
There has been much debate as to whether the ataxia in
patients with MFS arises from cerebellar pathology (cen-
tral) or from dysfunction of cerebellar afferents with in-
volvement of the proprioceptive spinocerebellar pathways
(peripheral). Existing case reports have commented on ab-
normalities found in the medulla and pons, indicating a
central nervous system pathology and also evidence of
peripheral neuropathy on neurophysiology, however there
are no reports of cerebellar abnormalities. The majority of
case reports describe normal appearances on magnetic
resonance imaging, although no MRS was performed
[3-8]. Some cases do report central involvement, however
this is not specifically cerebellar [9,10].
From the original work of Fisher, and from subsequent
publications, it was suggested that the cause of ataxia
might be due to selective involvement of Ia afferent neu-
rons along their path from muscle spindles to the spinal
cord [1,11]. The GQ1b antigen is highly expressed in the
oculomotor, trochlear and abducens nerves as well as in
muscle spindles in the limbs [12].
Evidence of direct cerebellar involvement has also
been proposed. For example Kim et al. have demon-
strated cerebellar (vermis and hemispheres) glucose hy-
permetabolism in 10 patients with MFS [13]. This
normalized after clinical recovery. Immunohistochemis-
try of human cerebellum using sera from patients with
MFS showed selective staining of the cerebellar molecu-
lar layer [14]. Pathological findings are limited due to
the good prognosis associated with MFS. However evi-
dence of loss of purkinje neurons in the cerebellum inpatients with MFS has been reported in autopsy speci-
mens [15].
This report supports cerebellar involvement in MFS in
addition to the peripheral neuropathy. In MR spectros-
copy, neuronal levels of creatine are stable, serving as a
reference point to measure the concentration of NAA,
which is decreased in malfunctioning neurons [12].
Therefore, the NAA/Cr ratio, obtained from MRS with
the voxel placed over the vermis and the cerebellar
hemispheres is a useful tool in identifying neuronal dys-
function and monitoring progression or improvement of
neuronal function [16-20]. In this case, MRS identified
significant reduction of NAA/Cr in both the vermis and
the right hemisphere whilst the patient was symptomatic
with normalization of the NAA/Cr 2.5 months later.
The change in MRS was significant [21].
Conclusion
Miller Fisher syndrome is associated with direct cerebellar
involvement in addition to the peripheral neuropathy. This
was demonstrated by abnormal spectroscopy of the
cerebellum during clinical evidence of ataxia and
normalization of the spectroscopy on clinical recovery.
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